<DOC>
	<DOCNO>NCT00592943</DOCNO>
	<brief_summary>The specific aim study 1 ) document Dopamine Transporter ( DAT ) receptor occupancy armodafinil use positron emission tomography ( PET ) scan C-11 altropane ligand 2 ) document increase intrasynaptic dopamine produce armodafinil use PET scan C-11 raclopride ligand . We hypothesize DAT occupancy low armodafinil ; le DAT occupancy produce therapeutic dos methylphenidate . We also hypothesize increase intrasynaptic dopamine relatively low armodafinil .</brief_summary>
	<brief_title>PET Study Examining Dopaminergic Activity Armodafinil Adults</brief_title>
	<detailed_description>Modafinil produce unique spectrum pharmacological effect include enhanced vigilance , arousal , wakefulness human subject ( Bastuji Jouvet 1988 ) . The drug widely use treat narcolepsy ( Banerjee , Vitiello et al . 2004 ) , also effective Attention Deficit Hyperactivity Disorder ( ADHD ) ( Biederman , Swanson et al . 2005 ) . Notwithstanding expand clinical indication modafinil , neurochemical mechanism produce therapeutic improvement remain unresolved . Pre-clinically , modafinil weak inhibitor DAT , display affinity dopamine receptor subtypes ( Mignot , Nishino et al . 1994 ) . Further evidence support low dopaminergic activity low abuse potential modafinil ( Jasinski 2000 ) . Various theory propose alternative mode action include enhancement glutamate release inhibition Gamma-aminobutyric acid ( GABA ) release various brain region ( Ferraro , Antonelli et al . 1997 ; Ferraro , Antonelli et al . 1997 ; Ferraro , Antonelli et al . 1999 ) . However , exact mechanisms action modafinil principle active metabolite , armodafinil , unknown . Understanding mechanisms action important assess potential therapeutic role armodafinil . We test see difference degree DAT occupancy D2 bind armodafinil compare traditional stimulant . The main target typical stimulant brain dopamine transporter ( DAT ) ( Volkow , Wang et al . 1998 ) . We exquisitely sensitive methodology measure DAT occupancy use C-11 altropane Positron Emission Tomography ( PET ) ( Fischman , Bonab et al . 2001 ) . Our group previously document central nervous system pharmacokinetics several psychiatric drug ( include methylphenidate ) use similar technique . ( Christian , Livni et al . 1996 ; Fischman , Bonab et al . 1996 ; Fischman , Alpert et al . 1997 ; Salazar Fischman 1999 ; Fischman , Alpert et al . 2002 ; Spencer , Biederman et al . 2006 ) . Increases intrasynaptic ( extracellular ) dopamine concentration associate medication routinely measure change C-11 raclopride bind PET scan . C-11 raclopride bind postsynaptic D-2 receptor . If intrasynaptic concentration dopamine increase , competes raclopride lead weak signal ( i.e . decrease raclopride bind D-2 receptor ) . After administration stimulant , associate increase intrasynaptic dopamine compete C-11 raclopride bind manner ( Volkow , Wang et al . 2002 ) . By use technology document change D-2 binding intrasynaptic space achieve armodafinil , compare achieve typical stimulant . To end , use two PET ligand ( C-11 altropane C-11 raclopride ) , protocol seek compare DAT receptor occupancy increase intrasynaptic dopamine produce armodafinil previous study methylphenidate . This research provide novel unique information toward good understanding mechanisms action armodafinil comparison typical stimulant .</detailed_description>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Dopamine Agonists</mesh_term>
	<criteria>1 . Signed write informed consent participate study . 2 . Age : 18 35 3 . If female , nonpregnant , nonnursing negative serum pregnancy test use adequate form birth control . 4 . Supine stand blood pressure within range 110/60 150/95 mmHg . 5 . Heart rate , rest 5 minute , within range 4690 beats/min . 6 . Righthanded . 1 . Diagnosis psychotic disorder , bipolar disorder , severe depression , severe anxiety , Autism . Subjects mild mood , oppositional , conduct , anxiety disorder may permit participate consider appropriate investigator . 2 . Scores Baseline Scales : Hamilton Depression Scale &gt; 17 ( possible 67 21item scale ) ( Hamilton 1960 ) Beck Depression Inventory &gt; 19 ( possible 63 21item scale ) ( Beck , Ward et al . 1961 ) Hamilton Anxiety Scale &gt; 21 ( possible 56 14item scale ) ( Hamilton 1959 ) 3 . Tics Tourette 's Syndrome . 4 . History head trauma loss consciousness , organic brain disorder , seizure , neurosurgical intervention . 5 . Any clinically significant chronic medical condition , judgment investigator . 6 . Mental impairment evidence I.Q . &lt; 75 . 7 . Exposure dopamine receptor antagonist within previous three ( 3 ) month . 8 . Exposure radiopharmaceutical within four ( 4 ) week prior PET scan . 9 . Subjects receive psychotropic medication . 10 . Any clinically significant abnormality screen laboratory test , vital sign , 11lead ECG , outside normal limit . 11 . Any woman childbearing potential seek become pregnant suspect may pregnant . 12 . Subjects know recent history ( within past six ( 6 ) month ) illicit drug alcohol dependence .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Adults</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Nuvigil</keyword>
	<keyword>Armodafinil</keyword>
	<keyword>DAT occupancy healthy volunteer</keyword>
</DOC>